ComboCap, Inc.

ComboCap, Inc., formerly known as Binutra USA, is a pioneering technology company that has created the groundbreaking ComboCap® Product Category. Founded in 2012, the company operates in the Pharmaceutical and Information Technology industries and is headquartered in the United States. The company's flagship product, the dual-chamber oral capsule with a movable membrane, has garnered substantial interest from investors. The patented technology developed by ComboCap, Inc. targets the rapidly expanding global market for combination therapy products, addressing the need for a universally appealing "wet & dry," split-dose solution. This innovative approach has attracted interest from private equity firm Athena Capital, which made a significant investment in the company on 01 January 2017. Recognizing the potential of ComboCap's specialized manufacturing equipment and services, investors have shown confidence in the company's ability to provide customized products and turn-key solutions to clients worldwide. As ComboCap, Inc. continues to make strides in the pharmaceutical and nutraceutical industries, its unique product offering and global potential position it as an intriguing investment opportunity for venture capitalists seeking innovation in the healthcare sector.